PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Computer model suggests genetic breast cancer screening may benefit those at intermediate risk

Study findings published in Cancer Prevention Research underscore viability of simulation modeling to stratify patients by disease risk to better focus resources where most beneficial

2013-12-05
(Press-News.org) Contact information: Kerry Sinclair
kerry.sinclair@gcihealth.com
310-710-0321
GCI Health
Computer model suggests genetic breast cancer screening may benefit those at intermediate risk Study findings published in Cancer Prevention Research underscore viability of simulation modeling to stratify patients by disease risk to better focus resources where most beneficial San Francisco, CA, USA – December 5, 2013 – Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for breast cancer was most cost effective when used to guide MRI screenings for patients found to have an intermediate lifetime risk of developing the disease. The study, "Cost-effectiveness of a genetic test for breast cancer risk," appeared in the December 5th online issue of the peer-reviewed journal Cancer Prevention Research.

"This Archimedes Model simulation suggests that genetic screening for breast cancer risk in conjunction with MRI can reduce cancer deaths and identifies a population at an intermediate risk near 20 percent for which it is optimally cost effective," said Tuan Dinh, PhD, vice president of analytics and modeling at Archimedes and one of the authors of study. "This study further illustrates that risk modeling may provide information that will enable physicians to better determine a patient's risk of disease and more appropriately allocate resources that will be beneficial."

In 2007, the American Cancer Society recommended MRI as an adjunct to mammography for the screening of breast cancer in women who have a lifetime risk of breast cancer of approximately 20-25 percent or greater as determined by models based on family history such as the Gail test. In the virtual study, researchers used Archimedes' detailed simulation model of breast cancer risk factors, disease progression, and healthcare processes to estimate the costs and benefits of using genetic testing to refine estimates of risk for purposes of referring women to MRI screening. The simulation included growth, detection, and spread of tumors, as well as screening and treatment.

The model compared two tests to categorize patients by lifetime risk, the Gail risk test and the 7SNP test. The Gail model, which is widely used by the National Cancer Institute, estimates risk using information on age, race, family history, and age of menarche and first live birth. The 7SNP genetic test uses the genotype of the patient to refine the estimate of the Gail test. In the simulated study, average-risk patients received an annual mammogram and high-risk patients received an annual MRI.

The simulated population consisted of 100,000 non-Hispanic white women starting at the age of 40 with no prior history of cancer and a lifetime Gail risk of breast cancer of at least 10 percent. Cancer incidence was based on Surveillance, Epidemiology, and End Results (SEER) data and validated to the Cancer Prevention Study II (CPS-II) Nutrition Cohort dataset. Risk factors were drawn from the National Health and Nutrition Examination Survey (NHANES-4) and Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial data. Mammogram characteristics were derived from Breast Cancer Surveillance Consortium data.

For patients with a lifetime risk of at least 10 percent, the model showed that the 7SNP test results in a 2.7 percent reduction in cancer deaths relative to the Gail test alone. For patients with a risk of 16-28 percent, the 7SNP test saved 0.005 quality-adjusted life years (QALY) per person at a cost of $163,264 per QALY. The cost effectiveness of using the 7SNP test for patients with intermediate Gail risk is similar to that of other recommended strategies, including annual MRI for patients with a lifetime risk greater than 20 percent or BRCA1/2 mutations, for which the model estimated a cost of $141,415 per QALY, relative to mammogram.

"These findings may help physicians and their patients as they strive to identify optimal breast cancer screening options for individual women based on their current risk profile," added Dr. Henri Folse, lead author of the study. "In addition, investigators can use mathematical modeling and cost-effectiveness analyses, such as those described in this study, to identify an optimal range of risk for which prevention and screening strategies are most cost effective."

This study was a collaborative project between Archimedes and Genetic Technologies Ltd.

INFORMATION:

ABOUT ARCHIMEDES

Archimedes, Inc. is a healthcare modeling and analytics organization. Its core technology - the Archimedes Model - is a clinically realistic, mathematical model of human physiology, diseases, interventions, and healthcare systems. Archimedes continually validates the Model by comparing the results of simulated trials to the results of multinational clinical trials and cohort studies. Through products such as IndiGO and ARCHeS, Archimedes helps people understand the implications of their decisions. For the last 15 years, Archimedes has assisted health plans, health systems, medical groups, patients, pharmaceutical companies, researchers, and other organizations in the United States and Europe answer questions related to health and economic outcomes research, policy creation, clinical trial design, and performance improvement. Archimedes, a Kaiser Permanente Innovation, is based in San Francisco, California. For more information about Archimedes and its product offerings, please visit the company's website at http://www.archimedesmodel.com

Media Contact:
Edie DeVine
GCI Health for Archimedes
edie.devine@gcihealth.com
415-365-8543

END



ELSE PRESS RELEASES FROM THIS DATE:

Social ties more important than biology when it comes to teen sleep problems

2013-12-05
Social ties more important than biology when it comes to teen sleep problems WASHINGTON, DC, December 2, 2013 — Medical researchers point to developmental factors, specifically the decline of the sleep-inducing hormone melatonin, as an explanation for ...

Blacks happier at work than whites despite fewer friends, less autonomy

2013-12-05
Blacks happier at work than whites despite fewer friends, less autonomy WASHINGTON, DC, December 2, 2013 — Despite working in more routine and less autonomous jobs, having fewer close friends at work, and feeling less supported by their coworkers, blacks ...

Pediatric infectious disease chief authors new vaccination guideline for immunocompromised patients

2013-12-05
Pediatric infectious disease chief authors new vaccination guideline for immunocompromised patients NEW HYDE PARK, NY – A new guideline released Thursday by the Infectious Diseases Society of America (IDSA) notes that most people with compromised ...

UCSB team discovers how to change cell types by flipping a single switch

2013-12-04
UCSB team discovers how to change cell types by flipping a single switch With few exceptions, cells don't change type once they have become specialized — a heart cell, for example, won't suddenly become a brain cell. However, new findings by researchers ...

Scripps leads first global snapshot of key coral reef fishes

2013-12-04
Scripps leads first global snapshot of key coral reef fishes Fishing has reduced vital seaweed eaters by more than 50 percent, report reveals In the first global assessment of its kind, a science team led by researchers at Scripps Institution of Oceanography ...

New insights into cancer evolution help define screening window of opportunity

2013-12-04
New insights into cancer evolution help define screening window of opportunity Genetic changes that occur as precancerous cells turn malignant could help researchers design new screening strategies SEATTLE – A new appreciation of how cancer cells evolve ...

Fruit pest targeted by genomic research

2013-12-04
Fruit pest targeted by genomic research The spotted wing drosophila, a major pest that targets berries and cherries and other fruits in the United States, Canada and Europe, is itself being targeted, thanks to groundbreaking genome sequencing at the University ...

Prostate cancer stem cells are a moving target, UCLA researchers say

2013-12-04
Prostate cancer stem cells are a moving target, UCLA researchers say UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies. Following ...

Radiographic imaging exposes relationship between obesity and cancer

2013-12-04
Radiographic imaging exposes relationship between obesity and cancer Even with healthy BMI, greater visceral fat may put older men at risk for cancer Researchers at the National Institute for Aging are working to improve understanding about ...

Intense 2-color double X-ray laser pulses: a powerful tool to study ultrafast processes

2013-12-04
Intense 2-color double X-ray laser pulses: a powerful tool to study ultrafast processes A team working at the SACLA X-ray Free-Electron Laser (XFEL) in Japan has succeeded in generating ultra-bright, two-color X-ray laser pulses, for the first time in the hard X-ray region. ...

LAST 30 PRESS RELEASES:

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

More scrutiny of domestic fishing fleets at ports could help deter illegal fishing

Scientists transform plastic waste into efficient CO2 capture materials

Discovery of North America’s role in Asia’s monsoons offers new insights into climate change

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies

Researchers discover massive geo-hydrogen source to the west of the Mussau Trench

Even untouched ecosystems are losing insects at alarming rates, new study finds

Adaptive visible-infrared camouflage with wide-range radiation control for extreme ambient temperatures

MD Anderson research highlights for September 5, 2025

Physicists create a new kind of time crystal that humans can actually see

Reminder: Final media invitation for EPSC-DPS2025 and details of media briefings on RAMSES and Juno missions

Understanding orderly and disorderly behavior in 2D nanomaterials could enable bespoke design, tailored by AI

JAMA Network launches JAMA+ Women's Health

Surface plasmon driven atomic migration mediated by molecular monolayer

ERC Starting Grant for five University of Groningen scientists

AI turns printer into a partner in tissue engineering

[Press-News.org] Computer model suggests genetic breast cancer screening may benefit those at intermediate risk
Study findings published in Cancer Prevention Research underscore viability of simulation modeling to stratify patients by disease risk to better focus resources where most beneficial